Vellenga E - Search Results

1

Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway.

Wierenga AT, Vogelzang I, Eggen BJ, Vellenga E. Wierenga AT, et al. Among authors: vellenga e. Exp Hematol. 2003 May;31(5):398-405. doi: 10.1016/s0301-472x(03)00045-6. Exp Hematol. 2003. PMID: 12763138 Free article.

2

LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells.

Schuringa JJ, van der Schaaf S, Vellenga E, Eggen BJ, Kruijer W. Schuringa JJ, et al. Among authors: vellenga e. Exp Cell Res. 2002 Mar 10;274(1):119-29. doi: 10.1006/excr.2001.5454. Exp Cell Res. 2002. PMID: 11855863 Free article.

3

Proteolytic degradation of Smad4 in extracts of AML blasts.

Wierenga AT, Eggen BJ, Kruijer W, Vellenga E. Wierenga AT, et al. Among authors: vellenga e. Leuk Res. 2002 Dec;26(12):1105-11. doi: 10.1016/s0145-2126(02)00054-1. Leuk Res. 2002. PMID: 12443883

4

HSP27 protects AML cells against VP-16-induced apoptosis through modulation of p38 and c-Jun.

Schepers H, Geugien M, van der Toorn M, Bryantsev AL, Kampinga HH, Eggen BJ, Vellenga E. Schepers H, et al. Among authors: vellenga e. Exp Hematol. 2005 Jun;33(6):660-70. doi: 10.1016/j.exphem.2005.03.009. Exp Hematol. 2005. PMID: 15911090 Free article.

5

Inhibition of the transforming growth factor beta (TGFbeta) pathway by interleukin-1beta is mediated through TGFbeta-activated kinase 1 phosphorylation of SMAD3.

Benus GF, Wierenga AT, de Gorter DJ, Schuringa JJ, van Bennekum AM, Drenth-Diephuis L, Vellenga E, Eggen BJ. Benus GF, et al. Among authors: vellenga e. Mol Biol Cell. 2005 Aug;16(8):3501-10. doi: 10.1091/mbc.e04-11-1033. Epub 2005 May 25. Mol Biol Cell. 2005. PMID: 15917296 Free PMC article.

6

Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.

Schepers H, Wierenga AT, Eggen BJ, Vellenga E. Schepers H, et al. Among authors: vellenga e. Exp Hematol. 2005 Jul;33(7):747-57. doi: 10.1016/j.exphem.2005.04.006. Exp Hematol. 2005. PMID: 15963850 Free article.

7

Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/progenitor cell proliferation.

Wierenga AT, Vellenga E, Schuringa JJ. Wierenga AT, et al. Among authors: vellenga e. Blood. 2010 Jun 3;115(22):4367-76. doi: 10.1182/blood-2009-10-250894. Epub 2010 Mar 25. Blood. 2010. PMID: 20339093 Free article.

8

STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha.

Wierenga AT, Schepers H, Moore MA, Vellenga E, Schuringa JJ. Wierenga AT, et al. Among authors: vellenga e. Blood. 2006 Jun 1;107(11):4326-33. doi: 10.1182/blood-2005-11-4608. Epub 2006 Feb 2. Blood. 2006. PMID: 16455947 Free article.

9

Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis.

Schepers H, Wierenga AT, van Gosliga D, Eggen BJ, Vellenga E, Schuringa JJ. Schepers H, et al. Among authors: vellenga e. Blood. 2007 Aug 15;110(4):1317-25. doi: 10.1182/blood-2006-10-052175. Epub 2007 May 2. Blood. 2007. PMID: 17475913 Free article.

10

STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.

Schepers H, van Gosliga D, Wierenga AT, Eggen BJ, Schuringa JJ, Vellenga E. Schepers H, et al. Among authors: vellenga e. Blood. 2007 Oct 15;110(8):2880-8. doi: 10.1182/blood-2006-08-039073. Epub 2007 Jul 13. Blood. 2007. PMID: 17630355 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters